» Articles » PMID: 18851840

Syndecan-4 Regulates Subcellular Localization of MTOR Complex2 and Akt Activation in a PKCalpha-dependent Manner in Endothelial Cells

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2008 Oct 15
PMID 18851840
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Mammalian target of rapamycin (mTOR) activity is regulated by assembly of two functionally distinct complexes, mTORC1 and mTORC2. In syndecan-4 (S4) null endothelial cells, mTORC2 activity is reduced, resulting in decreased Akt activation, while mTORC1 activity is increased. Levels of rictor, mLST8, and mSin-1 are unchanged in total cell lysates but decreased in the rafts of S4(-/-) endothelial cells, as is the level of PKCalpha. Expression of myristoylated-PKCalpha in S4(-/-) cells restores rictor, mLST8, and mSin-1 presence in the rafts and rescues Akt phosphorylation. PKCalpha knockdown mimics the effect of S4 deletion on mTORC2 localization and Akt activation. Reduced mTORC2 activity in S4(-/-) endothelial cells results in decreased FoxO1/3a and eNOS phosphorylation, decreased endothelial cell size, and increased arterial blood pressure in S4(-/-) mice. Thus, S4-dependent targeting of PKCalpha to the plasma membrane is required for recruitment of mTORC2 components to the rafts and Akt activation.

Citing Articles

Activation of the cell wall integrity pathway negatively regulates TORC2-Ypk1/2 signaling through blocking eisosome disassembly in Saccharomyces cerevisiae.

Nomura W, Inoue Y Commun Biol. 2024; 7(1):722.

PMID: 38862688 PMC: 11166964. DOI: 10.1038/s42003-024-06411-2.


The mTORC2 signaling network: targets and cross-talks.

Ragupathi A, Kim C, Jacinto E Biochem J. 2024; 481(2):45-91.

PMID: 38270460 PMC: 10903481. DOI: 10.1042/BCJ20220325.


Characterization of wooden breast myopathy: a focus on syndecans and ECM remodeling.

Pejskova L, Ronning S, Kent M, Solberg N, Host V, Thu-Hien T Front Physiol. 2023; 14:1301804.

PMID: 38130476 PMC: 10737271. DOI: 10.3389/fphys.2023.1301804.


COVID-19 of differing severity: from bulk to single-cell expression data analysis.

Tian L, He M, Fan H, Zhang H, Dong X, Qiao M Cell Cycle. 2023; 22(14-16):1777-1797.

PMID: 37486005 PMC: 10446813. DOI: 10.1080/15384101.2023.2239620.


Syndecan-4 as a genetic determinant of the metabolic syndrome.

Crocco P, Vecchie D, Gopalkrishna S, Dato S, Passarino G, Young M Diabetol Metab Syndr. 2023; 15(1):156.

PMID: 37461091 PMC: 10351106. DOI: 10.1186/s13098-023-01132-8.


References
1.
Kandel E, Hay N . The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res. 1999; 253(1):210-29. DOI: 10.1006/excr.1999.4690. View

2.
Ikenoue T, Inoki K, Yang Q, Zhou X, Guan K . Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. EMBO J. 2008; 27(14):1919-31. PMC: 2486275. DOI: 10.1038/emboj.2008.119. View

3.
Balconi G, Spagnuolo R, Dejana E . Development of endothelial cell lines from embryonic stem cells: A tool for studying genetically manipulated endothelial cells in vitro. Arterioscler Thromb Vasc Biol. 2000; 20(6):1443-51. DOI: 10.1161/01.atv.20.6.1443. View

4.
Echtermeyer F, Streit M, Saoncella S, Denhez F, Detmar M, Goetinck P . Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J Clin Invest. 2001; 107(2):R9-R14. PMC: 199172. DOI: 10.1172/JCI10559. View

5.
Simons M, Horowitz A . Syndecan-4-mediated signalling. Cell Signal. 2001; 13(12):855-62. DOI: 10.1016/s0898-6568(01)00190-5. View